Literature DB >> 32931112

A 16-year follow-up of patients with serious mental illness and co-occurring substance use disorder.

Robert E Drake1, Haiyi Xie2, Gregory J McHugo2.   

Abstract

Entities:  

Year:  2020        PMID： 32931112      PMCID： PMC7491638          DOI： 10.1002/wps.20793

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  6 in total

1.  The 10-year course of remission, abstinence, and recovery in dual diagnosis.

Authors:  Haiyi Xie; Robert E Drake; Gregory J McHugo; Lynn Xie; Anita Mohandas
Journal:  J Subst Abuse Treat       Date:  2010-07-03

Review 2.  Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.

Authors:  L Dixon
Journal:  Schizophr Res       Date:  1999-03-01       Impact factor: 4.939

Review 3.  Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis.

Authors:  Glenn E Hunt; Matthew M Large; Michelle Cleary; Harry Man Xiong Lai; John B Saunders
Journal:  Drug Alcohol Depend       Date:  2018-08-22       Impact factor: 4.492

Review 4.  A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders.

Authors:  Robert E Drake; Erica L O'Neal; Michael A Wallach
Journal:  J Subst Abuse Treat       Date:  2007-06-15

5.  Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders.

Authors:  Robert E Drake; Gregory J McHugo; Haiyi Xie; Melinda Fox; Joan Packard; Barbara Helmstetter
Journal:  Schizophr Bull       Date:  2006-03-08       Impact factor: 9.306

6.  Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia.

Authors:  W S Fenton; T H McGlashan
Journal:  Arch Gen Psychiatry       Date:  1991-11
  6 in total
  9 in total

1.  Excess mortality in a cohort of Brazilian patients with a median follow-up of 11 years after the first psychiatric hospital admission.

Authors:  Paulo Rossi Menezes; Cristina Marta Del-Ben; Daiane Leite da Roza; Marcos Gonçalves de Rezende; Régis Eric Maia Barros; João Mazzoncini de Azevedo-Marques; Jair Lício Ferreira Santos; Lilian Cristina Correia Morais; Carlos Eugenio de Carvalho Ferreira; Bernadette Cunha Waldvogel
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-05-31       Impact factor: 4.328

2.  Long-Term Outcomes of First-Admission Psychosis: A Naturalistic 21-Year Follow-Up Study of Symptomatic, Functional and Personal Recovery and Their Baseline Predictors.

Authors:  Victor Peralta; Elena García de Jalón; Lucía Moreno-Izco; David Peralta; Lucía Janda; Ana M Sánchez-Torres; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

Review 3.  Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses.

Authors:  Luigi Giuliani; Giulia Maria Giordano; Paola Bucci; Pasquale Pezzella; Francesco Brando; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2021-12-14       Impact factor: 4.157

4.  How to improve the physical health of people with severe mental illness? A multicentric randomized controlled trial on the efficacy of a lifestyle group intervention.

Authors:  Mario Luciano; Gaia Sampogna; Mario Amore; Ileana Andriola; Pietro Calcagno; Claudia Carmassi; Valeria Del Vecchio; Liliana Dell'Osso; Giorgio Di Lorenzo; Barbara Gelao; Vincenzo Giallonardo; Alessandro Rossi; Rodolfo Rossi; Alberto Siracusano; Andrea Fiorillo
Journal:  Eur Psychiatry       Date:  2021-11-23       Impact factor: 5.361

5.  Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal.

Authors:  Andrea Fiorillo; Norman Sartorius
Journal:  Ann Gen Psychiatry       Date:  2021-12-13       Impact factor: 3.455

Review 6.  Second-Generation Antipsychotics' Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders.

Authors:  Michele Fabrazzo; Salvatore Cipolla; Alessio Camerlengo; Francesco Perris; Francesco Catapano
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964

7.  The Complex Interplay Between Physical Activity and Recovery Styles in Patients With Severe Mental Disorders in a Real-World Multicentric Study.

Authors:  Gaia Sampogna; Mario Luciano; Matteo Di Vincenzo; Ileana Andriola; Enrico D'Ambrosio; Mario Amore; Gianluca Serafini; Alessandro Rossi; Claudia Carmassi; Liliana Dell'Osso; Giorgio Di Lorenzo; Alberto Siracusano; Rodolfo Rossi; Andrea Fiorillo
Journal:  Front Psychiatry       Date:  2022-07-11       Impact factor: 5.435

8.  Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects.

Authors:  Laura Orsolini; Simone Pompili; Umberto Volpe
Journal:  J Clin Med       Date:  2022-08-27       Impact factor: 4.964

9.  Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study.

Authors:  Giammarco Cascino; Rossella Ceres; Alessio Maria Monteleone; Paola Bucci; Giulia Maria Giordano; Silvana Galderisi; Palmiero Monteleone
Journal:  J Clin Med       Date:  2022-10-10       Impact factor: 4.964
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.